618 related articles for article (PubMed ID: 25420829)
1. Management of liver transplantation waiting list for decompensated cirrhosis in a Spanish tertiary hospital: differences between hepatitis C virus recipients and other etiologies.
Ibáñez Samaniego L; Pérez Valderas M; Fernández Yunquera A; Rincón Rodríguez D; López Baena JA; Matilla Peña A; Catalina Rodríguez MV; Clemente Ricote G; Bañares Cañizares R; Salcedo Plaza M
Transplant Proc; 2014 Nov; 46(9):3084-6. PubMed ID: 25420829
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of direct anti-HCV drugs improves early post-liver transplant survival and induces significant changes in waiting list composition.
Crespo G; Trota N; Londoño MC; Mauro E; Baliellas C; Castells L; Castellote J; Tort J; Forns X; Navasa M
J Hepatol; 2018 Jul; 69(1):11-17. PubMed ID: 29481821
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study.
Ferrarese A; Germani G; Gambato M; Russo FP; Senzolo M; Zanetto A; Shalaby S; Cillo U; Zanus G; Angeli P; Burra P
World J Gastroenterol; 2018 Oct; 24(38):4403-4411. PubMed ID: 30344424
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C Virus Positive Patients on the Waiting List for Liver Transplantation: Turnover and Characteristics of the Population on the Eve of the Therapeutic Revolution With Direct-Acting Antivirals.
Trapani S; Rizzato L; Masiero L; Ricci A; Morabito V; Peritore D; Fiaschetti P; Del Sordo E; Cacciotti AR; Montemurro A; Nanni Costa A
Transplant Proc; 2017 May; 49(4):658-666. PubMed ID: 28457366
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Virus Recurrence Occurs Earlier in Patients Receiving Donation After Circulatory Death Liver Transplant Grafts Compared With Those Receiving Donation After Brainstem Death Grafts.
Townsend SA; Monga MA; Nightingale P; Mutimer D; Elsharkawy AM; Holt A
Transplant Proc; 2017 Nov; 49(9):2129-2134. PubMed ID: 29149973
[TBL] [Abstract][Full Text] [Related]
7. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrence.
Song AT; Sobesky R; Vinaixa C; Dumortier J; Radenne S; Durand F; Calmus Y; Rousseau G; Latournerie M; Feray C; Delvart V; Roche B; Haim-Boukobza S; Roque-Afonso AM; Castaing D; Abdala E; D'Albuquerque LA; Duclos-Vallée JC; Berenguer M; Samuel D
World J Gastroenterol; 2016 May; 22(18):4547-58. PubMed ID: 27182164
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in Spain.
de la Rosa G; Fondevila C; Navasa M
Liver Transpl; 2016 Sep; 22(9):1259-64. PubMed ID: 27197947
[TBL] [Abstract][Full Text] [Related]
10. Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
Aqel B; Wijarnpreecha K; Pungpapong S; Taner CB; Reddy K; Leise M; Mi L; Dickson RC
J Hepatol; 2021 Apr; 74(4):873-880. PubMed ID: 33188903
[TBL] [Abstract][Full Text] [Related]
11. Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.
Flemming JA; Vagefi PA; Freise CE; Yao FY; Terrault NA
Liver Transpl; 2014 Oct; 20(10):1202-10. PubMed ID: 24961679
[TBL] [Abstract][Full Text] [Related]
12. Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.
Chhatwal J; Samur S; Kues B; Ayer T; Roberts MS; Kanwal F; Hur C; Donnell DM; Chung RT
Hepatology; 2017 Mar; 65(3):777-788. PubMed ID: 27906468
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies for patients with decompensated liver cirrhosis due to hepatitis C virus infection eligible for liver transplantation: real-life data from five German transplant centers.
Sandmann L; Dörge P; Wranke A; Vermehren J; Welzel TM; Berg CP; Grottenthaler JM; Weiss KH; Langel J; Sterneck M; von Wulffen M; Manns MP; Wedemeyer H; Hardtke S; von Hahn T
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1049-1056. PubMed ID: 30807443
[TBL] [Abstract][Full Text] [Related]
14. Outcome of hepatitis C-related liver transplantation in direct-acting antiviral era.
Choudhary NS; Saraf N; Saigal S; Rastogi A; Bhangui P; Thiagrajan S; Soin AS
Indian J Gastroenterol; 2020 Dec; 39(6):539-543. PubMed ID: 33230754
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation.
Pascasio JM; Vinaixa C; Ferrer MT; Colmenero J; Rubin A; Castells L; Manzano ML; Lorente S; Testillano M; Xiol X; Molina E; González-Diéguez L; Otón E; Pascual S; Santos B; Herrero JI; Salcedo M; Montero JL; Sánchez-Antolín G; Narváez I; Nogueras F; Giráldez Á; Prieto M; Forns X; Londoño MC
J Hepatol; 2017 Dec; 67(6):1168-1176. PubMed ID: 28842296
[TBL] [Abstract][Full Text] [Related]
16. Intention-to-treat survival analysis of hepatitis C virus/human immunodeficiency virus coinfected liver transplant: Is it the waiting list?
Araiz JJ; Serrano MT; García-Gil FA; Lacruz EM; Lorente S; Sánchez JI; Suarez MA
Liver Transpl; 2016 Sep; 22(9):1186-96. PubMed ID: 27114030
[TBL] [Abstract][Full Text] [Related]
17. Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT).
Sáez-González E; Vinaixa C; San Juan F; Hontangas V; Benlloch S; Aguilera V; Rubín A; García M; Prieto M; López-Andujar R; Berenguer M
Liver Int; 2018 Jun; 38(6):1022-1027. PubMed ID: 29105320
[TBL] [Abstract][Full Text] [Related]
18. Optimal timing for hepatitis C therapy in US patients eligible for liver transplantation: a cost-effectiveness analysis.
Njei B; McCarty TR; Fortune BE; Lim JK
Aliment Pharmacol Ther; 2016 Nov; 44(10):1090-1101. PubMed ID: 27640785
[TBL] [Abstract][Full Text] [Related]
19. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.
Daniel KE; Said A
Curr Gastroenterol Rep; 2018 Apr; 20(5):20. PubMed ID: 29623506
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients.
Sayiner M; Stepanova M; De Avila L; Golabi P; Racila A; Younossi ZM
Dig Dis Sci; 2020 Feb; 65(2):416-422. PubMed ID: 31451982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
